The PE Ratio as of December 2024 (TTM) for Tyra Biosciences, Inc. (TYRA) is -8.75

According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.75. This represents a change of -24.88% compared to the average of -11.65 of the last 4 quarters.

Tyra Biosciences, Inc. (TYRA) Historical PE Ratio (quarterly & annually)

How has TYRA PE Ratio performed in the past?

The mean historical PE Ratio of Tyra Biosciences, Inc. over the last ten years is -85.66. The current -8.75 PE Ratio has changed 921.53% with respect to the historical average. Over the past ten years (40 quarters), TYRA's PE Ratio was at its highest in in the December 2022 quarter at 4.11. The PE Ratio was at its lowest in in the September 2020 quarter at -62.47.

Tyra Biosciences, Inc. (TYRA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Tyra Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tyra Biosciences, Inc. (TYRA) Average PE Ratio

How has TYRA PE Ratio performed in the past?

The current PE Ratio of Tyra Biosciences, Inc. (TYRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tyra Biosciences, Inc. (TYRA) PE Ratio vs. Peers

How is TYRA’s PE Ratio compared to its peers?

Tyra Biosciences, Inc.’s PE Ratio is less than Connect Biopharma Holdings Limited (7.21), less than RAPT Therapeutics, Inc. (-0.63), less than Xilio Therapeutics, Inc. (-1.16), less than Mineralys Therapeutics, Inc. (-4.16), greater than Gracell Biotechnologies Inc. (-29.24), less than Theseus Pharmaceuticals, Inc. (-6.29), less than Monte Rosa Therapeutics, Inc. (-4.84), less than Design Therapeutics, Inc. (-7.53), less than Erasca, Inc. (-4.56), less than Werewolf Therapeutics, Inc. (-1.08), less than Ikena Oncology, Inc. (-1.24), less than Stoke Therapeutics, Inc. (-6.05), less than PMV Pharmaceuticals, Inc. (-1.47), less than Pharvaris N.V. (-7.34), less than Molecular Partners AG (-2.46), less than Century Therapeutics, Inc. (-0.67), greater than Edgewise Therapeutics, Inc. (-22.36), less than C4 Therapeutics, Inc. (-2.55), less than Cullinan Oncology, Inc. (-4.99),

Build a custom stock screener for Tyra Biosciences, Inc. (TYRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tyra Biosciences, Inc. (TYRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.